Advertisement

Advertisement

2014 Highlights of ASH in North America Meeting

Caroline Helwick / April 15, 2014 / 2014 Highlights of ASH in North America Meeting

Better Options Emerging for Salvage Therapy in Hodgkin Lymphoma

Emerging effective treatment options for salvage therapy in Hodgkin lymphoma were described by Anas Younes, MD, Chief of the Lymphoma Service at Memorial Sloan Kettering Cancer Center, New York, at th...

myelodysplastic syndromes

Caroline Helwick / May 15, 2014 / 2014 Highlights of ASH in North America Meeting

Forward Progress in Myelodysplastic Syndromes Is Largely in Genetics

Most recent advances in the management of myelodysplastic syndrome (MDS) are in the area of genetics, according to Steven Gore, MD, of Yale University School of Medicine, New Haven. “New genomics res...

Advertisement

Advertisement

Sep

18

Today In Oncology

Study Links BAP1 Protein to Tumor Suppression in Several Cancers

Risk of Second HPV-Associated Cancer Among Survivors of HPV-Associated Cancers

Researchers Identify Pitfall in PSMA PET Imaging Method

Childhood Nonlymphoid Leukemia Risk With Maternal Use of Hormonal Contraception

Fatal Toxicities Associated With Immune Checkpoint Inhibitor Treatment

;

Advertisement

Most Read Stories

Bevacizumab Treatment Beyond Disease Progression in Advanced NSCLC

Adjuvant Modified FOLFIRINOX Yields Unprecedented Survival in Pancreatic Cancer

ASCO/IDSA Clinical Practice Guideline Update: Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression

KEYNOTE-407: Pembrolizumab Plus Chemotherapy Benefits Response, Survival in Squamous NSCLC

First-Line Nab-Paclitaxel and Gemcitabine in Advanced Cholangiocarcinoma

Most Viewed Videos

Toni K. Choueiri, MD, and Lauren C. Harshman, MD on RCC: Results From the PROSPER Trial

David A. Tuveson, MD, PhD, on Progress in Pancreatic Cancer: Expert Perspective

Gabriel N. Hortobagyi, MD, on Breast Cancer Staging: New and Important Changes

Kathleen N. Moore, MD, on Ovarian Cancer: Results From the QUADRA Study

Peter Schmid, MD, PhD, on Triple-Negative Breast Cancer: Results From the PAKT Trial

© 2018 HSP News Service, L.L.C.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.